The importance of a well-structured pancreatic screening program for familial and hereditary pancreatic cancer Hans F. A. Vasen Editorial 04 December 2017 Pages: 1 - 3
Is there a genetic anticipation in breast and/or ovarian cancer families with the germline c.3481_3491del11 mutation? R. El TannouriE. AlbuissonE. Luporsi Original Article 10 May 2017 Pages: 5 - 14
Heightened perception of breast cancer risk in young women at risk of familial breast cancer Rachael GlasseyMoira O’ConnorSarah J. Hardcastle Original Article 13 May 2017 Pages: 15 - 22
A multi-gene panel study in hereditary breast and ovarian cancer in Colombia A. M. Cock-RadaC. A. OssaL. R. Gomez Original Article 20 May 2017 Pages: 23 - 30
Use of the BOADICEA Web Application in clinical practice: appraisals by clinicians from various countries Anne BrédartJean-Luc KopRita Schmutlzer Original Article Open access 16 June 2017 Pages: 31 - 41
The association of low penetrance genetic risk modifiers with colorectal cancer in lynch syndrome patients: a systematic review and meta-analysis Neil DonaldSalim MalikKevin J. Monahan Review Open access 15 May 2017 Pages: 43 - 52
Quality of life following prophylactic gynecological surgery: experiences of female Lynch mutation carriers Holly EtchegaryElizabeth DicksLesa Dawson Original Article 27 May 2017 Pages: 53 - 61
RNF43 is mutated less frequently in Lynch Syndrome compared with sporadic microsatellite unstable colorectal cancers Lochlan J. FennellMark ClendenningVicki L. J. Whitehall Short Communication 01 June 2017 Pages: 63 - 69
Contiguous gene deletion of chromosome 2p16.3-p21 as a cause of Lynch syndrome Erin E. Salo-MullenPatricio B. LynnZsofia K. Stadler Short Communication 29 May 2017 Pages: 71 - 77
Constitutional mismatch repair deficiency and Lynch syndrome among consecutive Arab Bedouins with colorectal cancer in Israel Naim Abu FrehaYaara Leibovici WeissmanZohar Levi Original Article 12 June 2017 Pages: 79 - 86
Co-occurrence of Lynch syndrome and juvenile polyposis syndrome confirmed by multigene panel testing Rachel Silva-SmithDaniel A. Sussman Short Communication 09 June 2017 Pages: 87 - 90
Somatic mutations of the coding microsatellites within the beta-2-microglobulin gene in mismatch repair-deficient colorectal cancers and adenomas Mark ClendenningAlvin HuangOn behalf of investigators from the Melbourne Collaborative Cohort Study and the Australasian Colorectal Cancer Family Registry Cohort Original Article 14 June 2017 Pages: 91 - 100
Development of a high risk pancreatic screening clinic using 3.0 T MRI Chad A. BarnesElizabeth KrzywdaSusan Tsai Original Article 03 November 2017 Pages: 101 - 111
Gestational choriocarcinoma associated with a germline TP53 mutation Anne-Claire BrehinSophie Patrier-SallebertThierry Frebourg Short Communication 05 May 2017 Pages: 113 - 117
TP53 germline and somatic mutations in a patient with fibrolamellar hepatocellular carcinoma Raissa C. AndradeMaria A. F. D. de LimaFernando R. Vargas Short Communication 05 May 2017 Pages: 119 - 122
Next generation sequencing is informing phenotype: a TP53 example R. O’SheaR. ClarkeD. J. Gallagher Original Article 16 May 2017 Pages: 123 - 128
Association of genetic variations in RTN4 3′-UTR with risk for clear cell renal cell carcinoma Yan PuPeng ChenLin Zhang Original Article 07 July 2017 Pages: 129 - 134
Early onset renal cell carcinoma in an adolescent girl with germline FLCN exon 5 deletion Meike SchneiderKatja DinkelborgOthon Iliopoulos Short Communication 16 June 2017 Pages: 135 - 139
Potentially pathogenic germline CHEK2 c.319+2T>A among multiple early-onset cancer families Mev Dominguez-ValentinSigve NakkenEivind Hovig Original Article 12 June 2017 Pages: 141 - 153
How do clinical genetics consent forms address the familial approach to confidentiality and incidental findings? A mixed-methods study Sandi DheensaGillian CrawfordAnneke Lucassen Original Article Open access 12 April 2017 Pages: 155 - 166
The role of screening MRI in the era of next generation sequencing and moderate-risk genetic mutations Sarah MacklinJennifer GassStephanie Hines Review 22 June 2017 Pages: 167 - 173
A single visit multidisciplinary model for managing patients with mutations in moderate and high-risk genes in a community practice setting Michael P. O’LearyBryan S. GoldnerHong Yoon Plurad Original Article 09 June 2017 Pages: 175 - 178
